Email Updates

Search form

You are here

31 MAY 2019 VOLUME 20 ISSUE 21

Media Coverage

  • When the first HIV drug, AZT, came to market in 1987, it cost $10,000 a year.... At the time, the price Burroughs Wellcome set for the drug sparked outrage. The AIDS epidemic was an urgent national crisis. For many, the diagnosis was a death sentence. The TV-viewing public was horrified by endless images of young men, suddenly sick and dying. A lost generation.

    May 30, 2019
    WNYC
  • The striking variation in HIV prevalence at provincial and district levels across countries in Sub-Saharan African calls for targeted interventions, a study suggests.

    May 30, 2019
    General
    SciDevNet
  • The outcome of the preliminary findings of the Nigerian HIV/AIDS Indicator and Impact Survey, NAIIS, has revealed that HIV prevalence was highest among women aged 35 and 49 with 3.3 percent and males aged 50 and above with 2.0 percent.

    May 30, 2019
    General
    Vanguard
  • Pharmacies throughout California could soon dispense an HIV-prevention drug without a doctor’s prescription — a move a San Francisco state senator says is necessary to remove barriers to people’s access to medication that could end new infections.

    May 30, 2019
    San Francisco Chronicle
  • The Ministry of Health and Welfare on Tuesday said it would grant insurance benefit for Truvada HIV-1 PrEP used for people who are negative in HIV-1 infection but at high risk due to sex with an HIV-positive partner, starting from June 7.

    May 30, 2019
    Korea Biomedical Review
  • Female animals were once deemed too hormonal and messy for science. Some scientists warn it’s not enough to just use more female lab rats.

    May 30, 2019
    General
    New York Times
  • Complacency, the United Nations warned in its latest report on AIDS, constitutes a grave threat to decades of progress against HIV. The report, a self-proclaimed “wake-up call,” was directed at the entire global health community. But its message is particularly urgent and personal for African women, who bear the brunt of the HIV pandemic but who are also in the vanguard of the fight against it.

    May 29, 2019
    General
    STAT News
  • Over a million girls are set to receive the Human Papilloma Virus (HPV) vaccine this week in Zimbabwe, a development likely to reduce the number of new cervical cancer cases.

    May 29, 2019
    Chronicle
  • The city of Cardenas has become Cuba’s trial-ground for a pilot experiment to prevent the transmission of the human immunodeficiency virus (HIV), the cause of AIDS, which if results are positive, could be implemented nationwide very soon.

    May 29, 2019
    Havana Times
  • Inspired by reports of a second patient apparently freed of infection with HIV, the virus that causes AIDS, scientists are pursuing dozens of ways to cure the disease. But now, researchers must reckon with a longstanding obstacle: the lack of women in clinical trials of potential HIV treatments, cures and vaccines.

    May 28, 2019
    General
    New York Times
  • World Health Organization members agreed on Tuesday to push for clearer drug pricing but stepped back from proposals by activists to force pharmaceutical firms to disclose the cost of making medicines.

    May 28, 2019
    General
    Reuters
  • Infants exposed to their mother’s antiretroviral treatment (ART) pre- and post-partum do not experience any significant poorer neurocognitive development compared to HIV-negative infants who are never exposed to HIV treatment, reassures a new study.

    May 28, 2019
    Avert
  • The study found South Africa’s HIV adult prevalence rate was much higher than most other countries, including Kenya (5.6 percent), Nigeria (3 percent), Namibia (13.8 percent), Zimbabwe (13.5 percent) and Mozambique (11.9 percent). But according to the research, South Africa’s high rate is partly because more people are living longer with HIV due to antiretroviral therapies.

    May 28, 2019
    General
    IOL
  • Barely months after the uproar caused by a Kenyan insurance company’s directive that doctors only prescribe generic medicines, the generic-versus-branded drugs debate has once again been resurrected by events thousands of miles away.

    May 27, 2019
    Daily Nation
  • The landscape of HIV treatment continues to shift and grow, with new and streamlined therapies introduced on a regular basis. People living with HIV today can lead very different lives than those of people who were diagnosed in the ’90s and early 2000s. Antiretroviral therapy (ART) makes it possible for a person living with HIV to experience complete viral suppression, even engaging in condomless sexual intercourse, or gestating a baby without fear of passing on the virus (Undetectable=Untransmittable).

    May 24, 2019
    Contagion Live

Published Research

Announcements